Clinical trial
BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic…
NCT00006086 · H. Lee Moffitt Cancer Center and Research Institute, Other · Completed
Key facts
| NCT number | NCT00006086 |
|---|---|
| Title | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer |
| Official title | Phase I Study of BMS-188797 in Combination With Carboplatin in Patients With Advanced Malignancies |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-188797, carboplatin |
| Start date | Jun 1, 2000 |
| Primary completion | Feb 1, 2003 |
| First posted | May 22, 2003 |
| Last update posted | Sep 9, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: